NYSE : NVO

Novo Nordisk A/S — Financial statements

Healthcare · Drug Manufacturers - General · Denmark

Last price 39.14 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 171.97B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Novo Nordisk A/S (NVO) reported revenue of 329.43B DKK (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in DKK.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue329.43B309.06B290.40B232.26B176.95B140.80B
Cost of Revenue59.34B54.38B43.56B35.32B28.42B23.66B
Gross Profit270.09B254.69B246.84B196.94B148.53B117.14B
Selling, General & Admin62.43B67.86B67.37B61.59B50.68B41.06B
Research & Development45.90B46.16B40.07B31.07B23.26B17.20B
Other Operating Expenses376.00M45.00M502.00M-425.00M-1.03B-332.00M
Operating Expenses108.71B114.07B107.94B92.24B72.91B57.92B
Operating Income161.38B140.62B138.90B104.70B75.62B59.22B
Interest Expense-103.00M-4.21B-1.64B-542.00M-378.00M-289.00M
Interest & Investment Income935.00M1.27B1.84B1.07B239.00M231.00M
Earnings From Equity Investments-17.00M-17.00M-17.00M81.00M-189.00M-24.00M
Currency Exchange Gain (Loss)6.01B6.01B-1.02B1.65B-4.65B344.00M
Other Non Operating Income (Expenses)-241.00M-241.00M-289.00M-197.00M-181.00M-122.00M
EBT Excluding Unusual Items167.97B143.43B137.77B106.76B70.46B59.36B
Merger & Restructuring Charges-9.37B-9.37B
Gain (Loss) on Sale of Investments71.00M71.00M-17.00M37.00M-587.00M296.00M
Asset Writedown-9.92B-3.59B-10.56B-2.12B-809.00M-573.00M
Pretax Income148.75B130.54B127.19B104.67B69.06B59.08B
Income Tax Expense32.31B28.11B26.20B20.99B13.54B11.32B
Net Income116.44B102.43B100.99B83.68B55.52B47.76B
Net Income to Common116.44B102.43B100.99B83.68B55.52B47.76B
Shares Outstanding (Basic)4.44B4.44B4.45B4.48B4.53B4.59B
Shares Outstanding (Diluted)4.45B4.45B4.46B4.49B4.54B4.61B
EPS (Basic)26.2223.0622.6718.6712.2610.40
EPS (Diluted)26.2023.0322.6318.6212.2210.37
Free Cash Flow75.84B58.96B73.80B83.10B66.74B48.66B
Free Cash Flow Per Share17.0613.2616.5418.4914.6910.56
Dividend Per Share11.7011.7011.409.406.205.20
Gross Margin81.99%82.41%85.00%84.79%83.94%83.20%
Operating Margin48.99%45.50%47.83%45.08%42.73%42.06%
Profit Margin35.35%33.14%34.77%36.03%31.38%33.92%
Free Cash Flow Margin23.02%19.08%25.41%35.78%37.72%34.56%
EBITDA173.68B153.29B145.69B110.74B81.12B63.77B
EBITDA Margin52.72%49.60%50.17%47.68%45.84%45.29%
D&A For EBITDA12.29B12.68B6.79B6.04B5.50B4.55B
EBIT161.38B140.62B138.90B104.70B75.62B59.22B
EBIT Margin48.99%45.50%47.83%45.08%42.73%42.06%
Effective Tax Rate21.72%21.53%20.60%20.05%19.60%19.17%

Balance sheet

Fiscal year January - December; amounts in DKK.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents44.48B26.46B15.65B14.39B12.65B10.72B
Short-Term Investments500.00M498.00M10.65B15.84B10.92B6.76B
Cash & Short-Term Investments44.98B26.96B26.31B30.23B23.57B17.48B
Accounts Receivable88.95B70.86B71.95B64.77B50.56B40.64B
Other Receivables19.56B18.33B16.36B10.49B6.95B6.16B
Receivables108.51B89.19B88.31B75.26B57.51B46.80B
Inventory51.35B49.62B40.85B31.81B24.39B19.62B
Other Current Assets3.85B6.68B6.33B2.34B2.73B1.69B
Total Current Assets208.70B172.45B161.79B139.65B108.19B85.59B
Property, Plant & Equipment231.76B208.38B161.68B90.96B66.67B55.36B
Long-Term Investments2.33B2.51B2.68B1.66B1.34B1.44B
Goodwill19.89B19.84B20.02B4.46B4.62B4.35B
Other Intangible Assets102.17B110.21B90.80B55.94B46.32B38.83B
Long-Term Deferred Tax Assets23.67B23.65B24.65B20.38B13.90B8.67B
Other Long-Term Assets6.43B5.86B4.02B1.43B206.00M267.00M
Total Assets594.94B542.90B465.63B314.49B241.26B194.51B
Accounts Payable14.59B19.76B17.14B25.61B15.59B8.87B
Accrued Expenses917.00M960.00M600.00M875.00M
Short-Term Debt928.00M5.79B456.00M480.00M12.86B
Current Portion of Long-Term Debt18.33B9.75B5.98B4.85B
Current Portion of Leases1.34B1.34B1.17B986.00M822.00M
Current Income Taxes Payable20.46B8.42B9.72B7.12B7.09B3.66B
Other Current Liabilities185.70B174.55B176.69B129.85B95.92B73.30B
Total Current Liabilities239.08B215.66B217.61B169.66B120.94B99.52B
Long-Term Debt113.17B111.70B84.25B15.98B20.77B9.65B
Long-Term Leases8.62B7.24B5.43B4.55B3.54B3.31B
Pension & Post-Retirement Benefits787.00M861.00M903.00M742.00M762.00M1.28B
Long-Term Deferred Tax Liabilities4.27B6.61B5.51B10.16B7.06B5.27B
Other Long-Term Liabilities7.73B6.78B8.44B6.84B4.69B4.73B
Total Liabilities373.66B348.86B322.14B207.93B157.77B123.76B
Common Stock446.00M446.00M446.00M451.00M456.00M462.00M
Retained Earnings224.16B195.30B144.45B104.84B80.59B72.00B
Treasury Stock-4.00M-2.00M-2.00M-5.00M-6.00M-6.00M
Comprehensive Income & Other-3.33B-1.70B-1.41B1.28B2.45B-1.71B
Shareholders' Equity221.28B194.05B143.49B106.56B83.49B70.75B
Total Liabilities & Equity594.94B542.90B465.63B314.49B241.26B194.51B
Total Debt140.13B130.96B102.79B27.01B25.78B26.64B
Net Cash (Debt)-95.14B-104.00B-76.48B3.22B-2.21B-9.16B
Net Cash Per Share-21.40-23.38-17.140.72-0.49-1.99
Filing Date Shares Outstanding4.43B4.44B4.44B4.46B4.50B4.56B
Total Common Shares Outstanding4.43B4.44B4.44B4.46B4.50B4.56B
Working Capital-30.39B-43.21B-55.83B-30.01B-12.75B-13.92B
Book Value Per Share49.9743.6632.3123.9018.5515.52
Tangible Book Value99.22B63.99B32.66B46.16B32.55B27.57B
Tangible Book Value Per Share22.4114.407.3610.357.236.05
Land65.56B61.37B48.99B43.40B41.08B
Machinery71.13B67.20B49.93B45.66B43.72B
Construction In Progress130.62B85.50B39.66B22.36B11.09B

Cash flow statement

Fiscal year January - December; amounts in DKK.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income116.44B102.43B100.99B83.68B55.52B47.76B
Depreciation & Amortization13.96B14.35B8.29B7.29B6.55B5.45B
Other Amortization318.00M318.00M255.00M
Asset Writedown & Restructuring Costs12.88B7.32B10.56B2.12B809.00M573.00M
Loss (Gain) From Sale of Investments4.16B4.16B-5.08B-556.00M2.57B
Loss (Gain) on Equity Investments17.00M17.00M17.00M-81.00M189.00M
Stock-Based Compensation1.44B1.44B2.29B2.15B1.54B
Other Operating Activities-8.63B-14.66B1.06B-5.41B17.23B10.28B
Change in Accounts Receivable1.09B1.09B-7.18B-14.21B-9.92B-12.91B
Change in Inventory-8.77B-8.77B-9.04B-7.42B-4.77B-1.08B
Change in Accounts Payable2.62B2.62B5.01B7.53B6.72B3.15B
Change in Other Net Operating Assets-3.64B8.80B13.79B33.82B2.43B1.78B
Operating Cash Flow131.88B119.10B120.97B108.91B78.89B55.00B
Capital Expenditures-56.04B-60.14B-47.16B-25.81B-12.15B-6.33B
Cash Acquisitions1.00B1.00B-82.16B-7.08B-18.28B
Sale (Purchase) of Intangibles-28.05B-29.97B-4.14B-13.09B-2.61B-1.05B
Investment in Securities33.00M9.95B4.58B-5.00B-3.09B-5.94B
Other Investing Activities-482.00M4.00M
Investing Cash Flow-83.54B-79.16B-128.90B-43.89B-24.92B-31.61B
Long-Term Debt Issued103.93B79.39B11.21B22.16B
Long-Term Debt Repaid-79.19B-6.33B-1.47B-13.62B-6.69B
Net Debt Issued (Repaid)36.44B24.74B73.06B-1.47B-2.41B15.47B
Repurchase of Common Stock-5.90B-1.39B-20.18B-29.92B-24.09B-19.45B
Common Dividends Paid-51.98B-51.76B-44.14B-31.77B-25.30B-21.52B
Financing Cash Flow-22.24B-28.41B8.73B-63.16B-51.80B-25.49B
Foreign Exchange Rate Adjustments-55.00M-727.00M455.00M-119.00M-238.00M591.00M
Net Cash Flow26.05B10.81B1.26B1.74B1.93B-1.51B
Free Cash Flow75.84B58.96B73.80B83.10B66.74B48.66B
Free Cash Flow Margin23.02%19.08%25.41%35.78%37.72%34.56%
Free Cash Flow Per Share17.0613.2616.5418.4914.6910.56
Levered Free Cash Flow37.67B376.88M60.57B54.55B57.50B43.90B
Unlevered Free Cash Flow37.74B3.01B61.60B54.89B57.73B44.08B
Cash Interest Paid4.23B3.42B612.00M491.00M272.00M261.00M
Cash Income Tax Paid30.92B32.01B29.64B25.90B14.52B14.44B
Change in Working Capital-8.70B3.74B2.59B19.71B-5.54B-9.06B

Ratios

Fiscal year January - December; amounts in DKK.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization175.43B227.21B384.85B461.55B304.43B256.20B
Enterprise Value189.64B238.00B382.37B458.43B302.77B252.89B
Last Close Price40.0049.2181.5697.3363.0951.67
PE Ratio10.1614.1127.4537.1938.1635.07
PS Ratio3.484.689.5513.4011.9711.90
PB Ratio5.197.4519.3229.2125.3823.68
P/TBV Ratio11.5722.5884.8767.4365.1060.74
P/FCF Ratio15.4624.5137.5637.4531.7534.42
P/OCF Ratio8.8912.1322.9228.5826.8630.45
EV/Sales Ratio3.774.909.4813.3111.9111.74
EV/EBITDA Ratio7.159.8818.9127.9225.9825.93
EV/EBIT Ratio7.6910.7719.8329.5327.8727.92
EV/FCF Ratio16.7125.6837.3237.2031.5733.97
Debt / Equity Ratio0.630.680.720.250.310.38
Debt / EBITDA Ratio0.800.850.700.240.310.41
Debt / FCF Ratio1.852.221.390.330.390.55
Net Debt / Equity Ratio0.430.540.53-0.030.030.13
Net Debt / EBITDA Ratio0.550.680.53-0.030.030.14
Net Debt / FCF Ratio1.251.761.04-0.040.030.19
Asset Turnover0.610.610.740.840.810.83
Inventory Turnover1.221.201.201.261.291.24
Quick Ratio0.640.540.530.620.670.65
Current Ratio0.870.800.740.820.900.86
Return on Equity (ROE)59.81%60.70%80.77%88.07%72.00%71.24%
Return on Assets (ROA)18.73%17.43%22.26%23.55%21.69%21.81%
Return on Invested Capital (ROIC)39.22%42.60%68.23%88.56%73.42%67.98%
Return on Capital Employed (ROCE)45.40%43.00%56.00%72.30%62.80%62.30%
Earnings Yield9.84%7.09%3.64%2.69%2.62%2.85%
FCF Yield6.47%4.08%2.66%2.67%3.15%2.90%
Dividend Yield3.20%3.60%1.83%1.35%1.32%1.42%
Payout Ratio32.54%50.53%43.71%37.96%45.57%45.05%
Buyback Yield / Dilution0.14%0.34%0.71%1.10%1.34%1.58%
Total Shareholder Return3.34%3.94%2.53%2.44%2.65%2.99%